Pancreatoduodenectomy Following Preoperative Biliary Drainage Using Endoscopic Ultrasound-Guided Choledochoduodenostomy Versus a Transpapillary Stent: A Multicenter Comparative Cohort Study of the ACHBT-FRENCH-SFED Intergroup.


Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 05 12 2022
accepted: 22 03 2023
medline: 7 7 2023
pubmed: 18 4 2023
entrez: 17 4 2023
Statut: ppublish

Résumé

It is unclear whether preoperative biliary drainage (PBD) by endoscopic retrograde cholangiopancreatography (ERCP) is equivalent to electrocautery-enhanced lumen-apposing metal stent (ECE-LAMS) before pancreatoduodenectomy (PD). Patients who underwent PBD for distal malignant biliary obstruction (DMBO) followed by PD were retrospectively included in nine expert centers between 2015 and 2022. ERCP or endoscopic ultrasound-guided choledochoduodenostomy with ECE-LAMS were performed. In intent-to-treat analysis, patients drained with ECE-LAMS were considered the study group (first-LAMS group) and those drained with conventional transpapillary stent the control group (first-cannulation group). The rates of technical success, clinical success, drainage-related complications, surgical complications, and oncological outcomes were analyzed. Among 156 patients, 128 underwent ERCP and 28 ECE-LAMS in first intent. The technical and clinical success rates were 83.5% and 70.2% in the first-cannulation group versus 100% and 89.3% in the first-LAMS group (p = 0.02 and p = 0.05, respectively). The overall complication rate over the entire patient journey was 93.7% in first-cannulation group versus 92.0% in first-LAMS group (p = 0.04). The overall endoscopic complication rate was 30.5% in first-cannulation group versus 17.9% in first-LAMS group (p = 0.25). The overall complication rate after PD was higher in the first-cannulation group than in the first-LAMS group (92.2% versus 75.0%, p = 0.016). Overall survival and progression-free survival did not differ between the groups. PBD with ECE-LAMS is easier to deploy and more efficient than ERCP in patients with DMBO. It is associated with less surgical complications after pancreatoduodenectomy without compromising the oncological outcome.

Sections du résumé

BACKGROUND BACKGROUND
It is unclear whether preoperative biliary drainage (PBD) by endoscopic retrograde cholangiopancreatography (ERCP) is equivalent to electrocautery-enhanced lumen-apposing metal stent (ECE-LAMS) before pancreatoduodenectomy (PD).
METHODS METHODS
Patients who underwent PBD for distal malignant biliary obstruction (DMBO) followed by PD were retrospectively included in nine expert centers between 2015 and 2022. ERCP or endoscopic ultrasound-guided choledochoduodenostomy with ECE-LAMS were performed. In intent-to-treat analysis, patients drained with ECE-LAMS were considered the study group (first-LAMS group) and those drained with conventional transpapillary stent the control group (first-cannulation group). The rates of technical success, clinical success, drainage-related complications, surgical complications, and oncological outcomes were analyzed.
RESULTS RESULTS
Among 156 patients, 128 underwent ERCP and 28 ECE-LAMS in first intent. The technical and clinical success rates were 83.5% and 70.2% in the first-cannulation group versus 100% and 89.3% in the first-LAMS group (p = 0.02 and p = 0.05, respectively). The overall complication rate over the entire patient journey was 93.7% in first-cannulation group versus 92.0% in first-LAMS group (p = 0.04). The overall endoscopic complication rate was 30.5% in first-cannulation group versus 17.9% in first-LAMS group (p = 0.25). The overall complication rate after PD was higher in the first-cannulation group than in the first-LAMS group (92.2% versus 75.0%, p = 0.016). Overall survival and progression-free survival did not differ between the groups.
CONCLUSIONS CONCLUSIONS
PBD with ECE-LAMS is easier to deploy and more efficient than ERCP in patients with DMBO. It is associated with less surgical complications after pancreatoduodenectomy without compromising the oncological outcome.

Identifiants

pubmed: 37069476
doi: 10.1245/s10434-023-13466-8
pii: 10.1245/s10434-023-13466-8
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5036-5046

Informations de copyright

© 2023. Society of Surgical Oncology.

Références

Tol JAMG, van Hooft JE, Timmer R, et al. Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer. Gut. 2016;65(12):1981–7. https://doi.org/10.1136/gutjnl-2014-308762 .
doi: 10.1136/gutjnl-2014-308762 pubmed: 26306760
Watanabe J, Miki A, Sasanuma H, Kotani K, Sata N. Metal versus plastic stents for preoperative biliary drainage in patients with periampullary cancer: An updated systematic review and meta-analysis. J Hepato Biliary Pancreat Sci. 2022. https://doi.org/10.1002/jhbp.1162 .
doi: 10.1002/jhbp.1162
Roberts AT, Jaya J, Ha P, et al. Metal stents are safe and cost-effective for preoperative biliary drainage in resectable pancreaticobiliary tumours. ANZ J Surg. 2021;91(9):1841–6. https://doi.org/10.1111/ans.17060 .
doi: 10.1111/ans.17060 pubmed: 34309143
Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102(8):1781–8. https://doi.org/10.1111/j.1572-0241.2007.01279.x .
doi: 10.1111/j.1572-0241.2007.01279.x pubmed: 17509029
Ekkelenkamp V, de Man R, ter Borg F, et al. Prospective evaluation of ERCP performance: results of a nationwide quality registry. Endoscopy. 2015;47(06):503–7. https://doi.org/10.1055/s-0034-1391231 .
doi: 10.1055/s-0034-1391231 pubmed: 25590180
Wang Q, Gurusamy KS, Lin H, Xie X, Wang C. Preoperative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev. 2008. https://doi.org/10.1002/14651858.CD005444.pub2 .
doi: 10.1002/14651858.CD005444.pub2 pubmed: 18843716 pmcid: 8889537
Mori S, Aoki T, Park K, et al. Impact of preoperative percutaneous transhepatic biliary drainage on post-operative survival in patients with distal cholangiocarcinoma. ANZ J Surg. 2019. https://doi.org/10.1111/ans.15329 .
doi: 10.1111/ans.15329 pubmed: 31625220
Inamdar S, Slattery E, Bhalla R, Sejpal DV, Trindade AJ. Comparison of adverse events for endoscopic versus percutaneous biliary drainage in the treatment of malignant biliary tract obstruction in an inpatient national cohort. JAMA Oncol. 2016;2(1):112. https://doi.org/10.1001/jamaoncol.2015.3670 .
doi: 10.1001/jamaoncol.2015.3670 pubmed: 26513013
Schaefer M, Albouys J, Legros R, et al. Endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) using electrocautery-enhanced lumen-apposing metal stent: the easiest way to perform EUS-CDS? Endoscopy. 2019;51(08):219–20. https://doi.org/10.1055/a-0885-9196 .
doi: 10.1055/a-0885-9196
Jacques J, Privat J, Pinard F, et al. Endoscopic ultrasound-guided choledochoduodenostomy with electrocautery-enhanced lumen-apposing stents: a retrospective analysis. Endoscopy. 2019;51(06):540–7. https://doi.org/10.1055/a-0735-9137 .
doi: 10.1055/a-0735-9137 pubmed: 30347424
Jacques J, Privat J, Pinard F, et al. EUS-guided choledochoduodenostomy by use of electrocautery-enhanced lumen-apposing metal stents: a French multicenter study after implementation of the technique (with video). Gastrointest Endosc. 2020;92(1):134–41. https://doi.org/10.1016/j.gie.2020.01.055 .
doi: 10.1016/j.gie.2020.01.055 pubmed: 32084411
Kunda R, Pérez-Miranda M, Will U, et al. EUS-guided choledochoduodenostomy for malignant distal biliary obstruction using a lumen-apposing fully covered metal stent after failed ERCP. Surg Endosc. 2016;30(11):5002–8. https://doi.org/10.1007/s00464-016-4845-6 .
doi: 10.1007/s00464-016-4845-6 pubmed: 26969661
Tsuchiya T, Teoh AYB, Itoi T, et al. Long-term outcomes of EUS-guided choledochoduodenostomy using a lumen-apposing metal stent for malignant distal biliary obstruction: a prospective multicenter study. Gastrointest Endosc. 2018;87(4):1138–46. https://doi.org/10.1016/j.gie.2017.08.017 .
doi: 10.1016/j.gie.2017.08.017 pubmed: 28843583
Anderloni A, Fugazza A, Troncone E, et al. Single-stage EUS-guided choledochoduodenostomy using a lumen-apposing metal stent for malignant distal biliary obstruction. Gastrointest Endosc. 2019;89(1):69–76. https://doi.org/10.1016/j.gie.2018.08.047 .
doi: 10.1016/j.gie.2018.08.047 pubmed: 30189198
Fabbri C. Beyond palliation: using EUS-guided choledochoduodenostomy with a lumen-apposing metal stent as a bridge to surgery a case series. J Gastrointestin Liver Dis. 2019. https://doi.org/10.15403/jgld.2014.1121.281.eus .
doi: 10.15403/jgld.2014.1121.281.eus pubmed: 30851182
Gaujoux S, Jacques J, Bourdariat R, et al. Pancreaticoduodenectomy following endoscopic ultrasound-guided choledochoduodenostomy with electrocautery-enhanced lumen-apposing stents an ACHBT–SFED study. HPB. 2021;23(1):154–60. https://doi.org/10.1016/j.hpb.2020.06.001 .
doi: 10.1016/j.hpb.2020.06.001 pubmed: 32646808
Neuzillet C, Gaujoux S, Williet N, et al. Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC). Dig Liver Dis. 2018;50(12):1257–71. https://doi.org/10.1016/j.dld.2018.08.008 .
doi: 10.1016/j.dld.2018.08.008 pubmed: 30219670
Dumonceau JM, Tringali A, Papanikolaou I, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline—Updated October 2017. Endoscopy. 2018;50(09):910–30. https://doi.org/10.1055/a-0659-9864 .
doi: 10.1055/a-0659-9864 pubmed: 30086596
Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71(3):446–54. https://doi.org/10.1016/j.gie.2009.10.027 .
doi: 10.1016/j.gie.2009.10.027 pubmed: 20189503
Clavien PA, Strasberg SM. Severity grading of surgical complications. Ann Surg. 2009;250(2):197–8. https://doi.org/10.1097/SLA.0b013e3181b6dcab .
doi: 10.1097/SLA.0b013e3181b6dcab pubmed: 19638901
Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13. https://doi.org/10.1016/j.surg.2005.05.001 .
doi: 10.1016/j.surg.2005.05.001 pubmed: 16003309
Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161(3):584–91. https://doi.org/10.1016/j.surg.2016.11.014 .
doi: 10.1016/j.surg.2016.11.014 pubmed: 28040257
Besselink MG, van Rijssen LB, Bassi C, et al. Definition and classification of chyle leak after pancreatic operation: a consensus statement by the international study group on pancreatic surgery. Surgery. 2017;161(2):365–72. https://doi.org/10.1016/j.surg.2016.06.058 .
doi: 10.1016/j.surg.2016.06.058 pubmed: 27692778
Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the international study group of pancreatic surgery (ISGPS). Surgery. 2007;142(5):761–8. https://doi.org/10.1016/j.surg.2007.05.005 .
doi: 10.1016/j.surg.2007.05.005 pubmed: 17981197
Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH)–An international study group of pancreatic surgery (ISGPS) definition. Surgery. 2007;142(1):20–5. https://doi.org/10.1016/j.surg.2007.02.001 .
doi: 10.1016/j.surg.2007.02.001 pubmed: 17629996
Smith RA, Dajani K, Dodd S, et al. Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2008;15(11):3138–46. https://doi.org/10.1245/s10434-008-0148-z .
doi: 10.1245/s10434-008-0148-z pubmed: 18787902
Eshuis WJ, Van der Gaag N, Rauws E, et al. Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg. 2010;252(5):840–9. https://doi.org/10.1097/SLA.0b013e3181fd36a2 .
doi: 10.1097/SLA.0b013e3181fd36a2 pubmed: 21037440
Maruthachalam K, Lash GE, Shenton BK, Horgan AF. Tumour cell dissemination following endoscopic stent insertion. Br J Surg. 2007;94(9):1151–4. https://doi.org/10.1002/bjs.5790 .
doi: 10.1002/bjs.5790 pubmed: 17541987
Yamashita S, Tanemura M, Sawada G, et al. Impact of endoscopic stent insertion on detection of viable circulating tumor cells from obstructive colorectal cancer. Oncol Lett. 2017. https://doi.org/10.3892/ol.2017.7339 .
doi: 10.3892/ol.2017.7339 pubmed: 29434882 pmcid: 5776945

Auteurs

Julien Janet (J)

Digestive Surgery Department, Dupuytren Limoges University Hospital, Limoges, France.

Jeremie Albouys (J)

Hepato-Gastroenterology Department, CHU Dupuytren, Limoges, France.
Faculté de Médecine de Limoges, Limoges, France.
CNRS, XLIM, UMR 7252, University of Limoges, Limoges, France.

Bertrand Napoleon (B)

Gastroenterology Department, Hôpital Privé Jean Mermoz, Ramsay Générale de Santé, Lyon, France.

Jeremie Jacques (J)

Hepato-Gastroenterology Department, CHU Dupuytren, Limoges, France.
Faculté de Médecine de Limoges, Limoges, France.

Muriel Mathonnet (M)

Digestive Surgery Department, Dupuytren Limoges University Hospital, Limoges, France.

Julien Magne (J)

CEBIMER, University of Limoges, Limoges, France.

Marie Fontaine (M)

Gastroenterology Department, Hôpital Privé Jean Mermoz, Ramsay Générale de Santé, Lyon, France.

Charles de Ponthaud (C)

Department of HPB and Endocrine Surgery, Hôpital la pitié salpêtrière, APHP, Paris, France.

Sylvaine Durand Fontanier (S)

Digestive Surgery Department, Dupuytren Limoges University Hospital, Limoges, France.
CNRS, XLIM, UMR 7252, University of Limoges, Limoges, France.

Sylvia S M Bardet (SSM)

CNRS, XLIM, UMR 7252, University of Limoges, Limoges, France.

Raphael Bourdariat (R)

Digestive Surgery Department, Hôpital Privé Jean Mermoz, Ramsay Générale de Santé, Lyon, France.

Laurent Sulpice (L)

Department of Digestive Surgery, CHU de Rennes, Rennes, France.
Faculté de Médecine de Rennes, Rennes, France.

Mickael Lesurtel (M)

Department of HPB Surgery, Beaujon Hospital, APHP, Clichy, France.

Romain Legros (R)

Hepato-Gastroenterology Department, CHU Dupuytren, Limoges, France.
Faculté de Médecine de Limoges, Limoges, France.
CNRS, XLIM, UMR 7252, University of Limoges, Limoges, France.

Stephanie Truant (S)

Depatment of Digestive Surgery and Transplantation, Hôpital Huriez - CHRU de Lille, Lille, France.

Fabien Robin (F)

Department of Digestive Surgery, CHU de Rennes, Rennes, France.
Faculté de Médecine de Rennes, Rennes, France.

Frédéric Prat (F)

Department of Endoscopy, Beaujon Hospital, APHP, Clichy, France.

Maxime Palazzo (M)

Endoscopy Unit, Hôpital Européen, Marseille, France.

Lilian Schwarz (L)

Digestive Surgery Department, CHU de Rouen, Rouen, France.

Emmanuel Buc (E)

Digestive Surgery Department, CHU de Clermont, Ferrand, France.

Alain Sauvanet (A)

Department of HPB Surgery, Beaujon Hospital, APHP, Clichy, France.

Sebastien Gaujoux (S)

Department of HPB and Endocrine Surgery, Hôpital la pitié salpêtrière, APHP, Paris, France.

Abdelkader Taibi (A)

Digestive Surgery Department, Dupuytren Limoges University Hospital, Limoges, France. abdelkader.taibi@chu-limoges.fr.
CNRS, XLIM, UMR 7252, University of Limoges, Limoges, France. abdelkader.taibi@chu-limoges.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH